Walleye Capital’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129K Sell
1,300
-6,700
-84% -$874K ﹤0.01% 3557
2025
Q4
$973K Sell
8,000
-10,600
-57% -$1.33M ﹤0.01% 2455
2025
Q3
$2.09M Sell
18,600
-13,700
-42% -$1.6M 0.01% 1546
2025
Q2
$4.33M Buy
32,300
+24,600
+319% +$2.7M 0.02% 965
2025
Q1
$518K Sell
7,700
-31,600
-80% -$2.17M ﹤0.01% 2533
2024
Q4
$2.45M Buy
39,300
+35,100
+836% +$3.27M 0.01% 1595
2024
Q3
$659K Sell
4,200
-8,700
-67% -$1.34M ﹤0.01% 3044
2024
Q2
$1.94M Buy
+12,900
New +$1.55M ﹤0.01% 2137
2023
Q4
Sell
-100
Closed -$5.47K 5517
2023
Q3
$5.47K Sell
100
-8,000
-99% -$576K ﹤0.01% 4576
2023
Q2
$680K Buy
8,100
+5,400
+200% +$413K ﹤0.01% 2193
2023
Q1
$204K Hold
2,700
﹤0.01% 2456
2022
Q4
$167K Hold
2,700
﹤0.01% 2150
2022
Q3
$113K Buy
+2,700
New +$117K ﹤0.01% 2373

Other funds holding TMDX

Walleye Capital's TMDX Position: Q1 2026 in Review

Walleye Capital increased its Transmedics (TMDX) stake by 34% in Q1 2026, buying an estimated $73.2K and bringing the position to 2,213 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #3279.

Walleye Capital first reported a position in TMDX in Q3 2021 and has held it in 11 quarters since. The position peaked at $5.26M in Q3 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Walleye Capital held 2,213 shares of Transmedics worth $220K as of Q1 2026.
  • Walleye Capital bought 561 Transmedics shares in Q1 2026, an estimated $73.2K.
  • Transmedics made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3279 holding.
  • Walleye Capital first reported a position in Transmedics in Q3 2021 and has held it in 11 quarters since.
  • Walleye Capital's Transmedics position peaked at $5.26M in Q3 2023.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.